#Hysteroscope Market

[johnblogs786]

Endometrial Ablation Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Reproductive Health Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Endometrial Ablation Devices market for the year 2020 and beyond. Endometrial Ablation Devices are used for treatment of Abnormal Menstrual Bleeding (Menorrhagia ). Endometrial Ablation Device is used for the removal of a portion of endometrial layer of the uterus and the endometrial layer is still functional but significant reduction in menstrual blood is observed. The procedure involved is Hysterectomy surgery for 1st generation technique whereas for 2nd generation techniques hysteroscope is not required.

[tamanna31]

New Trends of Uterine Manipulation Devices Market with Industry Analysis by 2024 – 2030

Uterine Manipulation Devices Industry Overview

The global uterine manipulation devices market size was valued at USD 283.23 million in 2023 and is projected to grow at a CAGR of 5.93% from 2024 to 2030.

The growth can be attributed to the growing adoption of minimally invasive procedures and rising technological advancements. Moreover, the growing prevalence of gynecological disorders such as cervical cancer, ovarian cysts, uterine fibroids, and endometriosis, among others, is anticipated to drive market growth. According to the data published by the WHO in March 2023, around 190 million or 10% of reproductive-age females and girls are affected by endometriosis across the globe.

Moreover, the growing adoption of minimally invasive procedures is anticipated to drive the market growth in the coming years. Minimally invasive procedures have numerous benefits over traditional open surgery, including less blood loss, decreased recovery time, and fewer complications. Due to these benefits, the demand for minimally invasive procedures among healthcare professionals and patients is rapidly growing. Numerous hysteroscopic procedures, such as laparoscopic hysterectomy and laparoscopic supracervical hysterectomy, are minimally invasive, and uterine manipulators are widely used during these procedures. Thus, the rising adoption of minimally invasive procedures is anticipated to drive the demand for uterine manipulation devices.

Gather more insights about the market drivers, restrains and growth of the Uterine Manipulation Devices Market

Furthermore, the increasing adoption of technologically advanced devices for hysteroscopy procedures is anticipated to propel the growth of the uterine manipulation devices market. Major industry players and stakeholders, such as research groups, focus on R&D  to develop novel products. They are aiming to introduce technologically advanced solutions to the market. For instance, in June 2023, researchers from the Biomechanics and Ergonomics research group partnered with the  General University Hospital of Castelló and the Fisabio Foundation to develop an innovative, atraumatic uterine manipulator that can be used in minimally invasive gynecological surgery. This device will be utilized in robotic/laparoscopic abdominal hysterectomies. Such developments are anticipated to support the market growth over the forecast period.

Moreover, the increasing number of studies on gynecological disorders and the evaluation of treatment devices, such as uterine manipulation devices, is expected to drive market growth in the coming years. For example, a study published by MDPI in April 2024 assessed a robotic uterine manipulation system, including a reusable and tiltable-tip uterine manipulator, for laparoscopic gynecologic surgery. The study found that the prototype of the uterine manipulator robot provides surgeons with cost-effective option, familiarity, sterilization, and a wide control range of the device without the need for a Remote Center of Motion (RCM) mechanism, which can cause incisions or fissures in the vulva. This growing focus on such studies is expected to spur innovation in the market.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global pediatric ENT market size was estimated at USD 7.19 billion in 2023 and is projected to grow at a CAGR of 5.02% from 2024 to 2030. 

The global dental suction systems market size was valued at USD 515.8 million in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to 2030.

Key Uterine Manipulation Devices Company Insights

Conkin Surgical Instrument Ltd., CooperSurgical Inc., B. Braun SE, KARL STORZ SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, Utah Medical Products, Inc., Purple Surgical, Laborie, and LSI Solutions, Inc. are some of the major players in the uterine manipulation devices market. These manufacturers provide different types of uterine manipulators, such as intrauterine manipulators and vaginal manipulators. Companies operating in the industry are expanding their presence in numerous countries and acquiring smaller players to bolster their presence in the market. In addition, the manufacturers are focusing on collaborations & partnerships to gain a competitive edge in the rapidly growing market.

Key Uterine Manipulation Devices Companies:

The following are the leading companies in the uterine manipulation devices market. These companies collectively hold the largest market share and dictate industry trends.

Conkin Surgical Instrument Ltd.

CooperSurgical Inc.

Braun SE

KARL STORZ SE & Co. KG

CONMED Corporation

Richard Wolf GmbH

Utah Medical Products, Inc.

Purple Surgical

Laborie

LSI Solutions, Inc.

Uterine Manipulation Devices

Recent Developments

In May 2024, Dr. Lutfi Kirdar Kartal Training and Research Hospital sponsored an interventional study to compare SecuFix and VCare Uterine Manipulators in Total Laparoscopic Hysterectomy. Around 10 participants aged between 35 and 65 were enrolled in this study.

In January 2023, Universita di Verona sponsored the clinical trial to study the oncologic outcomes of not using versus using the uterine manipulator in treating uterine-confined endometrial Carcinoma. Around 1,030 individuals are enrolled in this trial. This interventional study is estimated to be completed in December 2031.

In November 2023, CooperCompanies, a key industry player, acquired select Cook Medical assets concentrated primarily on the Doppler monitoring, obstetrics, and gynecology surgery markets

Order a free sample PDF of the Uterine Manipulation Devices Market Study, published by Grand View Research.

[bhushans]

The Rise of Tech-Driven Therapies: Reshaping the Global disposable endoscope market

The disposable endoscope market is expected to have grown to a valuation of US$ 1.3 billion, with a compound annual growth rate (CAGR) of 17.7% from 2023 to 2033. According to projections, the global market is expected to be worth US$ 6.8 billion by 2033. Disposable endoscopes are beginning to provide a simple solution to the global problem of surgical site infections. The availability of various medical instruments, such as laryngoscopes, proctoscopes, hysteroscopes, esophagogoscopes, bronchoscopes, and cystoscopes, may propel the global market.

Discover Industry Secrets Through Your Sample Report:  https://www.futuremarketinsights.com/reports/sample/rep-gb-15535

Combating Hospital Infections: Disposable Endoscopes Offer a Safe and Effective Solution

The global disposable endoscopes market is experiencing a surge in growth, driven by a critical need for safer surgical practices. Disposable endoscopes are revolutionizing endoscopy by reducing the risk of Hospital Acquired Infections (HAIs) associated with reusable endoscopes.

Multiple Factors Propelling Market Growth:

Several factors are contributing to the significant rise of the disposable endoscopes market:

Enhanced Patient Safety: Disposable endoscopes eliminate the risk of cross-contamination often associated with reprocessed reusable endoscopes, leading to improved patient safety outcomes.

Minimally Invasive Advantage: The growing preference for minimally invasive surgeries, which offer faster recovery times and reduced patient discomfort, is driving the demand for disposable endoscopes specifically designed for these procedures.

Chronic Disease Diagnosis: The rising prevalence of chronic diseases like cancer, inflammatory bowel disease, and respiratory illnesses is fueling the use of endoscopes for diagnosis and treatment, creating a larger market for disposable options.

Key Takeaways:

The global disposable endoscopes market is estimated to reach US$6.8 billion by 2033, reflecting a significant rise from US$1.3 billion in 2023.

This growth is projected at a remarkable compound annual growth rate (CAGR) of 17.7% throughout the forecast period.

The increasing adoption of minimally invasive procedures and the rising prevalence of chronic diseases are key drivers for market expansion.

Competitive Landscape:

The market is highly fragmented, with several competitors in the disposable endoscope production sphere. To meet the rising consumer demand and expand their customer base, these companies are implementing various strategies such as mergers & acquisitions, partnerships, collaborations, and new product launches.

Recent Industry Developments

In July 2022, Ambu Inc. received 510(k) regulatory clearance from the USA Food and Drug Administration (FDA) for its Ambu aScope 5 Broncho fifth-generation sterile bronchoscopes.

In May 2021, the PENTAX Medical ONE Pulmo, a brand-new single-use bronchoscope from PENTAX Medical Europe, bagged the CE mark. This ground-breaking product offers pulmonary treatment of the utmost quality. It is a disposable bronchoscope with enhanced suction power and high-resolution images.

Key Companies Profiled:

Ambu A/S

EndoLook

Medtronic Plc

HOYA Corporation

Flexicare Medical Limited

Disposable Endoscopes Market Segmentation:

By Product:

Bronchoscopes

Cystoscopes

Duodenoscopes

Esophagoscopes

Hysteroscopes

Laryngoscopes

Proctoscopes

Ureteroscopes

By End User:

Hospitals

Ambulatory Surgical Center

Diagnostic Center

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

The Middle East & Africa (MEA)

[iasrm]

Masterclass In Regenerative Medicine In Infertility

Masterclass In Regenerative Medicine In Infertility

Extensive practical & hands-on training on prp, bmac, svf, fat grafting, exosomes, amniotic membranes, amniotic fluid, placental extract, mesenchymal stem cells, bhrt and many advances in gynaecological diseases like thin endometrium, pre mature ovarian failure , early menopause, endometriosis, vaginal atrophy, azoospermia etc.

Objective

Our Aim is to educate fertility specialists in treating couples facing challenges to con-ceive due to:

Course Curriculum

Module 1: Basics Of Regenerative Medicine

Introduction, Definition, Classifications, Applications, Future Directions

Module 2: Platelet Rich Plasma Therapy

Definition, Classification, Prepararion, Manual & commercial kit based preparations, Applications, Inclusion Criteria, Exclusion Criteria, Informed consent, Pre & Post procedure requirements, Clinical studies and Future direction

Module 3: BMAC & Bone Marrow Derived Stemcells

Haematopoetic Stem Cells, Bone Marrow Aspiration, Site selection, Inclusion & exclusion criteria, BMAC Preparartion, Applications.

Module 4: Fat Grafting, Adipose Stemcells and Mesenchymal Stemcell Therapy Liposuction,site selection,preparation of Micro Fragmented Adipose tissues,Classification of macro, micro, nano fat, SVF, mesenchymal stemcells , procedure requirements, etc.

Module 5: Thin Endometrium & Asherman Syndrome

Detailed analysis, Clinical Trials, Protocols, Research Paper Reviews, Clinical Requirements, Protocols, IUI- Canula Injcetion Technique, Hysteroscopic Injection Technique and analysis, Result interpretation, TVS, Color Dopler , Hormone analysis , Further Directions for Natural cycle or IVF.

Module 6: Premature Ovarian Failure or Ovarian Insufficiency

Laparoscopic Injection Techniques and detailed analysis. Hormone Profile and MRI Analysis.

Module 7: Male Infertilty

Module-8: Erectile Dysfunction and Penile Enlargement

Cell therapy and holistic approach of management, hormones & nutraceuticals therapy, shockwave therapy.

Module-9: Bio-identical Hormone Replacement Therapy, Nutraceutical IV Therapy, HBOT(Hyperbaric ozygen therapy) and other holistic and detox treatments for fertility.

Module-10: How to Start Regenerative Medicine in your Clinic / IVF centre. Laboratory Guidance, Regulatory & Ethical Requirements. Manpower and Technical Requirements.

Module-11: How Regenerative Medicine is in Industry

Marketing, Commercialisation, Investment and funding. How to market your clinics & create awareness.

Course Details

Duration: 04 Days

Hours of Teaching: 32

Mode:Live Demonstration, Hybrid & Handson.

All Live Demonstration will be in OR Of Hospital/ Clincal Set Up.

Venue: New Delhi India

Certificate: Certificate will be provided by International Association of Stemcell & Regenerative Medicine . In collaboration with Clinical Partner Sunrise Hospital & NewLife Surgery.

Academic Partner: Sharda University.

International Partner: Romanian Society of Aesthetic Gynaecology.

Fee

Practical and Hands-On Training

Online lecture and Demonstration(Video)

Course Offered By IASRM ( International Association of Stem Cell & Regenerative Medicine )

MASTERCLASS

1: Masterclass in Cosmetic Gynaecology

2: Masterclass In Regenerative Medicine In Infertility

3: Masterclass In Regenerative Orthopaedics & Pain Management

4: Masterclass In Regenerative Aesthetic Andrology , Urogynaecology & Sexual Medicine

5: Master Course In Stem Cell & Regenerative Medicine

6: Masterclass In Platelet Rich Plasma (PRP)

FELLOWSHIPS

1: Fellowship In Regenerative Medicine In Infertility

2: Fellowship In Stemcell And Regenerative Medicine

3: Fellowship In Cosmetic Gynaecology

4: Fellwoship In Regenerative Aesthetic Functional Gynaecology & Cosmetic Andrology

[adorefem]

Gynae Products: Unlocking Lucrative Business Opportunities in Women’s Health

Introduction:

Women’s health is an integral part of the healthcare industry, and it continues to gain recognition and importance in the global market. For entrepreneurs and business enthusiasts, the field of gynaecology (Gynae) products presents a wealth of opportunities. In this blog, we delve into the world of Gynae products, highlighting the business prospects and potential for growth in this dynamic sector.

Gynae Products: A Growing Niche in Healthcare:

The term “Gynae products” encompasses a wide range of pharmaceuticals, medical devices, and healthcare solutions that cater to the unique health needs of women. As women’s health gains greater awareness and understanding, the demand for innovative Gynae products continues to rise. Here’s an exploration of the various business opportunities within this niche:

1. Contraceptives and Family Planning:

Contraceptives play a pivotal role in women’s reproductive health. This category includes a variety of products, such as birth control pills, intrauterine devices (IUDs), and contraceptive implants. Entrepreneurs can tap into the family planning segment by manufacturing or distributing these essential products, empowering women to make informed choices about their reproductive health.

2. Menstrual Health and Hygiene:

A woman’s menstrual health is an essential part of her life. Manufacturing and marketing sanitary napkins, tampons, menstrual cups, and period pain relievers are among the business opportunities in this market. Businesses can significantly impact women’s menstrual health by offering safe and effective solutions.

3. Reproductive Health and Fertility:

Reproductive health products address a range of issues, from fertility and ovulation tracking to treatments for conditions like polycystic ovary syndrome (PCOS). Entrepreneurs can explore opportunities in producing fertility medications, ovulation kits, and other reproductive health solutions to help women on their journey to parenthood.

4. Maternal and Prenatal Care:

Pregnancy and childbirth are transformative life experiences, and the demand for maternal and prenatal care products is consistently high. Entrepreneurs can venture into this sector by manufacturing prenatal vitamins, supplements, and maternity wear. Additionally, creating innovative products that enhance the overall pregnancy and childbirth experience can be a lucrative opportunity.

5. Gynaecological Infections and Treatments:

Infections in the gynaecological tract are common health concerns for women. Business opportunities lie in producing antibiotics, antifungal medications, and antiviral drugs to address these issues effectively. Offering innovative treatment options can provide value to both healthcare providers and patients.

6. Hormone Replacement Therapy (HRT):

Hormone replacement therapy is often prescribed to manage menopausal symptoms and hormone imbalances. Entrepreneurs can explore this segment by manufacturing HRT products, including hormone patches, creams, and oral medications, which help women maintain their quality of life during menopause.

7. Medical Devices and Equipment:

The demand for medical devices and equipment used in gynaecological examinations and procedures is on the rise. Entrepreneurs can invest in manufacturing or distributing tools like ultrasound machines, colposcopes, hysteroscopes, and other diagnostic and surgical instruments that enable healthcare professionals to provide comprehensive care.

8. Gynaecological Surgical Instruments:

Gynaecological surgeries are performed for various reasons, including the removal of fibroids, treatment of endometriosis, and addressing gynaecological cancers. Manufacturing and supplying surgical instruments, such as laparoscopic and hysteroscopic tools, can be a profitable venture, given the increasing demand for minimally invasive procedures.

The Regulatory Landscape:

When venturing into the Gynae products business, it is essential to be well-versed in the regulatory requirements specific to your product category. Ensuring that your products comply with national and international regulations is crucial for market entry and long-term success. Regulatory compliance guarantees product safety and quality, instilling confidence in both healthcare providers and consumers.

Marketing and Distribution:

To succeed in the Gynae products market, entrepreneurs must develop effective marketing and distribution strategies. Establishing a strong online presence, attending relevant medical conferences and exhibitions, and collaborating with healthcare professionals are critical components of your marketing efforts. Additionally, building a robust distribution network ensures that your products reach healthcare facilities, pharmacies, and consumers efficiently.

Challenges and Competition:

The Gynae products market is highly competitive, with many established players and new entrants vying for a share of the market. Challenges include staying updated on the latest medical advancements, responding to evolving consumer preferences, and managing intense competition. However, these challenges also present opportunities for innovation and differentiation.

Conclusion:

Gynae products represent a promising and impactful niche within the healthcare industry. Entrepreneurs who recognize the importance of women’s health and the growing demand for innovative Gynae products are well-positioned to thrive in this dynamic sector. Whether it’s addressing women’s reproductive health, menstrual hygiene, or maternal care, the Gynae products business offers a chance to make a meaningful difference in the lives of women while building a successful enterprise. With a commitment to quality, regulatory compliance, and effective marketing strategies, entrepreneurs can unlock the immense potential for growth and prosperity in the field of women’s health.

Source: https://adorefem.wordpress.com/2023/11/06/gynae-products-unlocking-lucrative-business-opportunities-in-womens-health/